Ampicha Nawai1, Suzanne G Leveille2,3,4, Robert H Shmerling3,4, Guusje van der Leeuw2, Jonathan F Bean4,5,6. 1. College of Nursing and Health Sciences, University of Massachusetts Boston, Boston, MA, USA. ampicha.nawai001@umb.edu. 2. College of Nursing and Health Sciences, University of Massachusetts Boston, Boston, MA, USA. 3. Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA. 4. Harvard Medical School, Boston, MA, USA. 5. New England Geriatric, Research, Education and Clinical Center, Boston Veterans Administration Health System, Boston, MA, USA. 6. Spaulding Rehabilitation Hospital, Boston, MA, USA.
Abstract
BACKGROUND: Concerns about polypharmacy and medication side effects contribute to undertreatment of geriatric pain. This study examines use and effects of pharmacologic treatment for persistent pain in older adults. METHODS: The MOBILIZE Boston Study included 765 adults aged ≥70 years, living in the Boston area, recruited from 2005 to 2008. We studied 599 participants who reported chronic pain at baseline. Pain severity, measured using the Brief Pain Inventory (BPI) severity subscale, was grouped as very mild (BPI <2), mild (BPI 2-3.99), and moderate to severe (BPI 4-10). Medications taken in the previous 2 weeks were recorded from medication bottles in the home interview. RESULTS: Half of participants reported using analgesic medications in the previous 2 weeks. Older adults with moderate to severe pain were more likely to use one or more analgesic medications daily than those with very mild pain (49 versus 11%, respectively). The most commonly used analgesic was acetaminophen (28%). Opioid analgesics were used daily by 5% of participants. Adjusted for health and demographic factors, pain severity was strongly associated with daily analgesic use (moderate-severe pain compared to very mild pain, adj. OR 7.19, 95% CI 4.02-12.9). Nearly one third of participants (30%) with moderate to severe pain felt they needed a stronger pain medication while 16% of this group were concerned they were using too much pain medication. CONCLUSION: Serious gaps persist in pain management particularly for older adults with the most severe chronic pain. Greater efforts are needed to understand barriers to effective pain management and self-management in the older population.
BACKGROUND: Concerns about polypharmacy and medication side effects contribute to undertreatment of geriatric pain. This study examines use and effects of pharmacologic treatment for persistent pain in older adults. METHODS: The MOBILIZE Boston Study included 765 adults aged ≥70 years, living in the Boston area, recruited from 2005 to 2008. We studied 599 participants who reported chronic pain at baseline. Pain severity, measured using the Brief Pain Inventory (BPI) severity subscale, was grouped as very mild (BPI <2), mild (BPI 2-3.99), and moderate to severe (BPI 4-10). Medications taken in the previous 2 weeks were recorded from medication bottles in the home interview. RESULTS: Half of participants reported using analgesic medications in the previous 2 weeks. Older adults with moderate to severe pain were more likely to use one or more analgesic medications daily than those with very mild pain (49 versus 11%, respectively). The most commonly used analgesic was acetaminophen (28%). Opioid analgesics were used daily by 5% of participants. Adjusted for health and demographic factors, pain severity was strongly associated with daily analgesic use (moderate-severe pain compared to very mild pain, adj. OR 7.19, 95% CI 4.02-12.9). Nearly one third of participants (30%) with moderate to severe pain felt they needed a stronger pain medication while 16% of this group were concerned they were using too much pain medication. CONCLUSION: Serious gaps persist in pain management particularly for older adults with the most severe chronic pain. Greater efforts are needed to understand barriers to effective pain management and self-management in the older population.
Entities:
Keywords:
Analgesic medications; Epidemiology; Older adults; Pain; Side effects
Authors: San Keller; Carla M Bann; Sheri L Dodd; Jeff Schein; Tito R Mendoza; Charles S Cleeland Journal: Clin J Pain Date: 2004 Sep-Oct Impact factor: 3.442
Authors: Carrie Stewart; Suzanne G Leveille; Robert H Shmerling; Elizabeth J Samelson; Jonathan F Bean; Pat Schofield Journal: J Am Geriatr Soc Date: 2012-11-05 Impact factor: 5.562
Authors: Manu Thakral; Ling Shi; Janice B Foust; Kushang V Patel; Robert H Shmerling; Jonathan F Bean; Suzanne G Leveille Journal: Pain Date: 2016-12 Impact factor: 7.926
Authors: Giulia Ogliari; Jesper Ryg; Karen Andersen-Ranberg; Lasse Lybecker Scheel-Hincke; Jemima T Collins; Alison Cowley; Claudio Di Lorito; Louise Howe; Katie R Robinson; Vicky Booth; David A Walsh; John R F Gladman; Rowan H Harwood; Tahir Masud Journal: Eur Geriatr Med Date: 2022-10-13 Impact factor: 3.269
Authors: Manu Thakral; Ling Shi; Janice B Foust; Kushang V Patel; Robert H Shmerling; Jonathan F Bean; Suzanne G Leveille Journal: Geriatr Nurs Date: 2018-02-21 Impact factor: 2.361
Authors: Tuuli Elina Lehti; M-O Rinkinen; U Aalto; H M Roitto; M Knuutila; H Öhman; H Kautiainen; H Karppinen; R Tilvis; T Strandberg; K H Pitkälä Journal: Drugs Aging Date: 2021-08-13 Impact factor: 3.923